Starboard Value Reportedly Acquires $1B Stake in Pfizer as Stock Lags S&P 500 by 46%
Despite these challenges, Pfizer maintains a strong cash position of $7.1 billion and offers an attractive forward dividend yield of 5.74%. The company’s stock performance has lagged behind the S&P 500 index, with a one-year return of -10.72% compared to the index’s 35.98% gain.